JMCR Partners, a family office founded in 2013, manages private assets and invests in biotech and healthcare sectors.
30
Operating
2013
Victoria, Central and Western District, HK
JMCR Partners, a family office established in 2013, focuses on investments in the biotechnology and healthcare sectors. The firm manages private assets for the founder's family and close relations through its subsidiaries, including JMCR Capital, JMCR Partners, and JMRE. Their investment strategy typically targets Series A and B rounds.
Notable portfolio companies include SQZ Biotechnologies, FunPlus, and Stripe. JMCR Partners has also invested in promising biotech firms such as Anji Pharmaceuticals, Mirata Pharmaceuticals, and Viva Biotech. The firm's investment approach emphasizes supporting innovative companies in the healthcare and biotechnology industries, contributing to advancements in these critical sectors.
Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies9
Follow-on Investments2
Current Portfolio Count8
Top Investment Stages
Series A6 (60.0%)
Series B2 (20.0%)
Seed1 (10.0%)
Series C1 (10.0%)
Stage Mix
Series A 60%Series B 20%Seed 10%Series C 10%
Concentration shown as share of disclosed investments by stage.
